JULY 2015 ARTICLE LIST >>
PharmaTutor (July- 2015)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 7)
Received On: 9/03/2015; Accepted On: 27/03/2015; Published On: 01/07/2015
AUTHORS: *Ashif I. Bhim1, Farhana V. Buchiy1, Hasumati A. Raj1, Vineet C. Jain2
1Department of Qaulity Assurane, Shree Dhanvantary Pharmacy College, Kim, Surat, Gujarat, India.
2Department of Pharmacognocy, Shree Dhanvantary Pharmacy College, Kim, Surat, Gujarat, India.
bhimiqbal23@gmail.com
ABSTRACT: A simple, accurate and precise spectroscopic method was developed for simultaneous estimation of Itopride Hydrochloride and Lansoprazole in synthetic mixture using first order derivative zero-crossing method. Itopride Hydrochlorideshowed zero crossing point at 278.12nmwhile Lansoprazole showed zero crossing point at 244.58nm. The dA/dλ was measured at 244.12 nm for Itopride Hydrochloride and 278.12nmfor Lansoprazole and calibration curves were plotted as dA/dλ versus concentration, respectively. The method was found to be linear (r2>0.999) in the range of 5-25μg/ml for Itopride Hydrochloride at 244.58nm. The linear correlation was obtained (r2>0.996) in the range of 5-25 μg/ml for Lansoprazole at 278.12 nm. The limit of determination was 0.155μg/ml and 0.059μg/ml forItopride Hydrochloride and Lansoprazole, respectively. The limit of quantification was 0.472μg/ml and 0.179μg/ml for Itopride Hydrochloride and Lansoprazolerespectively. The accuracy of these method were evaluated by recovery studies and good recovery result were obtained greater than 99% shows first order derivation zero crossing. The method was successfully applied for simultaneous determination of Itopride Hydrochloride and Lansoprazolein binary mixture.
How to cite this article: AI Bhim, FV Buchiy, HA Raj, VC Jain; Simultaneous determination of Itopride Hydrochloride and Lansoprazole in Synthetic Mixture using Spectrophotometric technique (First order Derivative Method); PharmaTutor; 2015; 3(7); 38-45
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Itopride, “Drug profile”
en.wikipedia.org/wiki/itopride
2. Lansoprazole, “Drug profile”
en.wikipedia.org/wiki/Lansoprazole
3. “Prevacid (Lansoprazole) Drug Information: Clinical Pharmacology”, May 2012,
rxlist.com/prevacid-drug/clinical-pharmacology.html
4. Santosh UZ, Paresh IK, Jitendra WG, Anantwar SP and Sahebrao SB, “Spectrophotometric method development and validation of Itopride Hydrochloride in bulk and dosage form.” Int. J. Drug Delivery. 2010,6, 340-343.
5. Gupta KR, Joshi RR, Chawla RB and Wadodkar SG, “UV Spectrophotometric Method for the Estimation of Itopride Hydrochloride in Pharmaceutical Formulation.” E-J. Chem.2010, 7, S49-S54.
6. Balram C, Anju G and Sukhbir LK, “Spectrophotometric method for estimation of Itopride Hydrochloride from tablets formulations using Methyl orange reagent.” Int. J. Pharm. & Pharm. Sci. 2009, 1, 159-162.
7. Pattanayaka, Sharma R and Chaturvedi SC, “Simultaneous estimation of Rabeprazole sodium and Itopride Hydrochloride.” Anal. Lett. 2007, 40, 2288-2294.
8. Anil K, Venkata R, Narasimha R and Sudhakara R, “Simple UV spectrophotometric method for determination of Lansoprazole in bulk and pharmaceutical dosage forms.” Int. J. Pharm. Chem. & Bio. sci. 2012, 2, 524-528.
9. Alagar R, Satish KY, Amit R and Suchita M, “Analytical estimation of Lansoprazole and validation of simple spectrophotometric in bulk and capsule formulation.” Int.J. Res. in Pharm. Sci. 2011, 2, 521-524.
10. Zenita DO, Basavaiah K, Ramesh PJ and Vinay KB, “Development of a simple UV-spectrophotometric method for the determination of lansoprazole and study of its degradation profile.” Quimica Nova. 2012, 35, 386-391.
11. Nisha C, Inamullah S, Jyoti R, Sunil S, Sharma S and Hemendar G, “Simultaneous estimation of Lansoprazole and naproxen by using UV spectrophotometer in tablet dosage form.” Der Pharm. Chem. 2013, 5, 67-74.
12. International Conference on Harmonization, Harmonized Tripartite Guideline, Validation of Analytical Procedures Text and Methodology, ICH Q2 (R1), 2005.
.png)
